|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 310 IDR | -0.64% |
|
-8.82% | +26.02% |
PT Diagnos Laboratorium Utama Tbk reported earnings results for the nine months ended September 30, 2023. For the nine months, the company reported sales was IDR 107,114.29 million compared to IDR 143,827.88 million a year ago. Net loss was IDR 10,650.72 million compared to net income of IDR 12,159.8 million a year ago.
Basic loss per share from continuing operations was IDR 8.520578 compared to basic earnings per share from continuing operations of IDR 9.72784 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +26.02% | 24.12M | |
| -16.58% | 8.49B | |
| +58.90% | 4.08B | |
| -39.78% | 2.42B | |
| -10.33% | 2.42B | |
| -8.91% | 2.33B | |
| -2.53% | 2.01B | |
| -19.90% | 1.53B | |
| -38.30% | 1.26B | |
| +2.19% | 1.07B |
PT DIAGNOS LABORATORIUM UTAMA TBK 
